Texas Attorney General Takes Legal Action Against Tylenol Makers Concerning Autism Spectrum Claims

The top legal official in Texas Paxton is filing a lawsuit against the producers of Tylenol, alleging the corporations hid potential risks that the pain reliever created to children's neurological development.

This legal action follows four weeks after Donald Trump publicized an unproven link between using Tylenol - alternatively called paracetamol - throughout gestation and autism in young ones.

Paxton is taking legal action against the pharmaceutical giant, which once produced the medication, the exclusive pain medication approved for expectant mothers, and Kenvue, which presently makes it.

In a statement, he claimed they "misled consumers by making money from suffering and promoting medication ignoring the potential hazards."

The manufacturer states there is insufficient reliable data linking acetaminophen to autism spectrum disorder.

"These companies deceived for years, deliberately risking countless individuals to boost earnings," the attorney general, from the Republican party, stated.

The company said in a statement that it was "deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its website, Kenvue also said it had "continuously evaluated the applicable studies and there is insufficient valid information that indicates a proven link between taking paracetamol and autism."

Associations acting on behalf of doctors and health professionals concur.

ACOG has stated acetaminophen - the main ingredient in acetaminophen - is among limited choices for women during pregnancy to manage discomfort and elevated temperature, which can create serious health risks if ignored.

"In multiple decades of studies on the utilization of paracetamol in pregnancy, not a single reputable study has successfully concluded that the consumption of acetaminophen in any trimester of gestation causes brain development issues in offspring," the association said.

The court filing mentions recent announcements from the former administration in arguing the drug is allegedly unsafe.

Last month, the former president generated worry from public health officials when he instructed women during pregnancy to "fight like hell" not to use Tylenol when unwell.

The US Food and Drug Administration then released a statement that doctors should consider limiting the usage of Tylenol, while also mentioning that "a proven link" between the medication and autism in children has not been proven.

Health Secretary RFK Jr, who supervises the FDA, had promised in April to conduct "extensive scientific investigation" that would establish the origin of autism in a matter of months.

But specialists advised that finding a sole reason of autism spectrum disorder - thought by researchers to be the outcome of a complex mix of inherited and external influences - would be difficult.

Autism is a type of lifelong neurodivergence and disability that affects how individuals perceive and relate to the world, and is diagnosed using medical professional evaluations.

In his lawsuit, the attorney general - aligned with the former president who is seeking federal office - claims Kenvue and J&J "intentionally overlooked and sought to suppress the science" around paracetamol and autism spectrum disorder.

The case aims to force the companies "eliminate any marketing or advertising" that asserts acetaminophen is reliable for women during pregnancy.

The court case mirrors the complaints of a group of guardians of minors with autism spectrum disorder and ADHD who filed suit against the producers of Tylenol in two years ago.

Judicial authorities threw out the legal action, stating research from the family's specialists was not conclusive.